This Lear Analyst Turns Bullish; Here Are Top 4 Upgrades For Tuesday

Avalyn Pharma AVLN	0.00	0.00%
Booz Allen Hamilton BAH	0.00	0.00%
BayCom BCML	0.00	0.00%
Cognex CGNX	0.00	0.00%
Connect Biopharma CNTB	0.00	0.00%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

TD Cowen analyst Itay Michaeli upgraded Lear Corporation (NYSE:LEA) from Hold to Buy and raised the price target from $138 to $165. Lear shares closed at $139.80 on Friday. See how other analysts view this stock.
Stifel analyst Jonathan Siegmann upgraded Booz Allen Hamilton Holding Corporation (NYSE:BAH) from Hold to Buy and lowered the price target from $115 to $110. Booz Allen Hamilton shares closed at $78.68 on Friday. See how other analysts view this stock.
JP Morgan analyst Jimmy Bhullar upgraded The Travelers Companies, Inc. (NYSE:TRV) from Underweight to Neutral and raised the price target from $316 to $322. Travelers shares closed at $306.46 on Friday. See how other analysts view this stock.
JP Morgan analyst Tomohiko Sano upgraded Cognex Corporation (NASDAQ:CGNX) from Neutral to Overweight and raised the price target from $65 to $75. Cognex shares closed at $66.09 on Friday. See how other analysts view this stock.

Considering buying LEA stock? Here’s what analysts think:

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.